Common (1% to 10%): Itching, pruritus, rash, urticaria Rare (0.01% to 0.1%): Bullous rashes, cutaneous lupus erythematosus, erythema multiforme, erythematous rashes, hair loss, hair thinning, hyperhidrosis, petechia, photosensitivity, purpura, serious dermatological reactions, Stevens-Johnson syndrome...
itching of the vagina or genital area pain during sexual intercourse rigidity sweating thick, white vaginal discharge with no odor or with a mild odor Less common side effects black, tarry stools chest pain cough loose stools painful or difficult urination ...
sustained and substantial improvement in pruritus and ODS, using the stringent endpoints of PP-NRS 0 or 1 and ODS 0 or 1.ClinicalTrials.gov identifier: NCT03428646.Atopic dermatitis (AD) is a long-term condition with rashes, inflammation and intense itching that disturbs sleep and daily ...
Common (1% to 10%): Erythema, rashes (including photosensitivity), pruritus, hives Uncommon (0.1% to 1%): Urticaria, accelerated diffuse hair loss Frequency not reported: Diaphoresis Postmarketing reports: Alopecia, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]Cardiovascu...
Frequency not reported: Pruritus, urticaria, other skin rashes, sweating[Ref]Musculoskeletal Frequency not reported: Muscle twitching, muscle rigidity[Ref] Endocrine Frequency not reported: Adrenal insufficiency, androgen deficiency[Ref]Hepatic Frequency not reported: Biliary spasm, choledochoduodenal sphinct...
The most common clinical toxicity was rash. Rashes were usually mild to moderate, maculopapular erythematous cutaneous eruptions, with or without pruritus, located on the face, trunk, and extremities. Rash has occurred most often during the first 6 weeks of therapy. Utilization of the 14-day le...
Common(1% to 10%): Rashes (generalized, macular, maculopapular, erythematous), pruritus, eczema, dermatitis,allergic dermatitis Uncommon(0.1% to 1%): Photosensitivity[Ref] Cardiovascular Very common(10% or more): QT prolongation (28%)
Uncommon(0.1% to 1%): Pruritus, urticaria, other skin rashes Rare(less than 0.1%): Hemorrhagic urticaria[Ref] Sweating often persists during chronic administration.[Ref] Hepatic Uncommon(0.1% to 1%): Bile duct dyskinesia[Ref] Local Frequency not reported: Local tissue reactions (pain, erythema,...
Common (1% to 10%): Pruritus, skin eruptions, ecchymoses, sweating, purpura Uncommon (0.1% to 1%): Skin rashes Postmarketing reports: Alopecia, urticaria, skin rashes, toxic epidermal necrolysis, erythema multiforme, erythema nodosum, fixed drug eruption, lichen planus, pustular reaction, systemic...
Postmarketing reports: Hypersensitivity reactions such as angioedema, anaphylactic reactions, auricular swelling, bullous conditions, exfoliative conditions, urticaria, pruritus, rashes, eruptions, exanthemasPsychiatric Methylphenidate products: Postmarketing reports: Disorientation, libido changes, hallucination, ...